Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 10000 participants.
Also called NCT03418974
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 10,000 participants
- Registry
-
NCT03418974
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03418974. Non-randomized; no masking; primary purpose treatment. Start 2017-11-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
- Condition
- Dyslipidemias
- Intervention (Drug)
- Pitavastatin
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- Fudan University
- Collaborator
- Peking University People's Hospital
- Collaborator
- Jiangsu Wanbang Medicine Marketing Co., Ltd.
Record details
- Record id
cardio:ct-nct03418974- Content hash
517d5e0cb4ad186bec3b3b13a2dea16a55cc97b9196a87e8345ccf54389ebfd5